Skip to main content
. 2016 Jun 28;5:e14845. doi: 10.7554/eLife.14845

Figure 5. ephrin-B2 mediates cytokinesis in the absence of anchorage through RhoA.

(a) Representative fluorescent images of binucleated cells grown in suspension for 24 hr and stained with phalloidin (green) to label cortical actin and EdU (red) to distinguish cycling from arrested cells. Scale bar = 20 μm. (b) Quantification of binucleated cells in indicated attached and suspended cultures. Values represent percentages over total number of cells. n = 4, error bars denote s.e.m. Two way ANOVA with Tukey post hoc test. (c) Western analysis of RhoA pulldown assays showing levels of activated RhoA (RhoA-GTP) and total RhoA levels in indicated cells grown in suspension for 24 hr . Bottom graph shows quantifications of activated RhoA levels from the western blots. n = 3. Error bars indicate s.e.m. (d) Quantification of the PI cell cycle profile as measured by FACS. Cells transfected with either constitutively active RhoA (V14) or dominant negative RhoA (N19) were grown in suspension for 24 hr . n = 3, error bars depict s.e.m. One way ANOVA with Tukey post hoc test was used to calculate p values for differences in G2/M phase of each suspended culture relative to corresponding attached cultures. See also Figure 5—figure supplement 1 and Figure 5—source data 1.

DOI: http://dx.doi.org/10.7554/eLife.14845.025

Figure 5—source data 1. Raw data for quantifications of binucleated cells and cell cycle analysis presented in Figure 5.
DOI: 10.7554/eLife.14845.026

Figure 5.

Figure 5—figure supplement 1. Src and FAK do not mediate anchorage-independent proliferation downstream of ephrin-B2.

Figure 5—figure supplement 1.

(a) Western analysis of levels of indicated proteins in imNSC1, imNSC1-Efnb2 and GSC1 cultured in attachment (a) and suspension (s). n = 2 (b) Western analysis of RhoA pulldown assays showing levels of activated RhoA (RhoA-GTP) and total RhoA levels following transfection of imNSC1 with constitutively active RhoA (V14) and GSC1 with dominant negative RhoA (N19). Note that as expected V14 activates RhoA and N19 inhibits RhoA, confirming efficacy of the mutant constructs. Bottom graph shows quantifications of activated RhoA levels from the western blots. n = 2. (c) Representative DNA cell-cycle profiles of indicated cells transfected with empty vector control (ctrl), dominant negative RhoA (N19) or constitutively active RhoA construct (V14) and cultured in methylcellulose for 24 hr. n = 3.